Mutations in the X-linked RSK2 gene (RPS6KA3) in patients with Coffin-Lowry syndrome
- PMID: 11180593
- DOI: 10.1002/1098-1004(200102)17:2<103::AID-HUMU2>3.0.CO;2-N
Mutations in the X-linked RSK2 gene (RPS6KA3) in patients with Coffin-Lowry syndrome
Abstract
RSK2 is a growth factor-regulated serine-threonine protein kinase, acting in the Ras-Mitogen-Activated Protein Kinase (MAPK) signaling pathway. Mutations in the RSK2 gene (RPS6KA3) on chromosome Xp22.2, have been found to cause Coffin-Lowry syndrome (CLS), an X-linked disorder characterized by psychomotor retardation, characteristic facial and digital abnormalities, and progressive skeletal deformations. By screening of 250 patients with clinical features suggestive of Coffin-Lowry syndrome, 71 distinct disease-associated RSK2 mutations have been identified in 86 unrelated families. Thirty-eight percent of mutations are missense mutations, 20% are nonsense mutations, 18% are splicing errors, and 21% are short deletion or insertion events. About 57% of mutations result in premature translation termination, and the vast majority are predicted to cause loss of function of the mutant allele. These changes are distributed throughout the RSK2 gene and show no obvious clustering or phenotypic association. However, some missense mutations are associated with milder phenotypes. In one family, one such mutation was associated solely with mild mental retardation. It is noteworthy that nine mutations were found in female probands, with no affected male relatives, ascertained through learning disability and mild but suggestive facial and digital dysmorphisms.
Copyright 2001 Wiley-Liss, Inc.
Similar articles
-
Identification of novel mutations in the RSK2 gene (RPS6KA3) in patients with Coffin-Lowry syndrome.Clin Genet. 2006 Aug;70(2):161-6. doi: 10.1111/j.1399-0004.2006.00660.x. Clin Genet. 2006. PMID: 16879200
-
X-linked Coffin-Lowry syndrome (CLS, MIM 303600, RPS6KA3 gene, protein product known under various names: pp90(rsk2), RSK2, ISPK, MAPKAP1).Eur J Hum Genet. 2002 Jan;10(1):2-5. doi: 10.1038/sj.ejhg.5200738. Eur J Hum Genet. 2002. PMID: 11896450
-
Mutations in the kinase Rsk-2 associated with Coffin-Lowry syndrome.Nature. 1996 Dec 12;384(6609):567-70. doi: 10.1038/384567a0. Nature. 1996. PMID: 8955270
-
[Coffin-Lowry syndrome].Ryoikibetsu Shokogun Shirizu. 2000;(30 Pt 5):163-5. Ryoikibetsu Shokogun Shirizu. 2000. PMID: 11057180 Review. Japanese. No abstract available.
-
A syndromic form of X-linked mental retardation: the Coffin-Lowry syndrome.Eur J Pediatr. 2002 Apr;161(4):179-87. doi: 10.1007/s00431-001-0904-6. Eur J Pediatr. 2002. PMID: 12014383 Review.
Cited by
-
Activation of p90 Rsk1 is sufficient for differentiation of PC12 cells.Mol Cell Biol. 2004 Dec;24(24):10573-83. doi: 10.1128/MCB.24.24.10573-10583.2004. Mol Cell Biol. 2004. PMID: 15572664 Free PMC article.
-
Epigenetic modulations in activated cells early after HIV-1 infection and their possible functional consequences.PLoS One. 2015 Apr 13;10(4):e0119234. doi: 10.1371/journal.pone.0119234. eCollection 2015. PLoS One. 2015. PMID: 25875202 Free PMC article.
-
First female Korean child with Coffin-Lowry syndrome: a novel variant in RPS6KA3 diagnosed by exome sequencing and a literature review.Ann Pediatr Endocrinol Metab. 2023 Mar;28(1):67-72. doi: 10.6065/apem.2142134.067. Epub 2022 Jan 18. Ann Pediatr Endocrinol Metab. 2023. PMID: 35038833 Free PMC article.
-
Histones and their chaperones: Adaptive remodelers of an ever-changing chromatinic landscape.Front Genet. 2022 Nov 16;13:1057846. doi: 10.3389/fgene.2022.1057846. eCollection 2022. Front Genet. 2022. PMID: 36468032 Free PMC article. Review.
-
RNF12 X-Linked Intellectual Disability Mutations Disrupt E3 Ligase Activity and Neural Differentiation.Cell Rep. 2018 May 8;23(6):1599-1611. doi: 10.1016/j.celrep.2018.04.022. Cell Rep. 2018. PMID: 29742418 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
